Visual Overview
05
Oncode Accelerator: Highlights & Updates
In this overview, we present a snapshot of our progress, consortium updates, media attention and major milestones from the first months of Oncode Accelerator.
First real-time patient data
By the end of 2023, the first real-time patient data was successfully sent to the Dutch Cancer Registry (DCR). In the coming period, the DCR will be made ready to make real-time, real world data available to our 'Well-defined patient cohorts' platform.
Read more
Cell and gene therapy in academic pharma
The Cell and Gene Therapy workstream partners have published their first scientific article on ATMP development in academic pharma. Acknowledging Oncode Accelerator for their support, this article offers valuable perspectives on the role of GMP simulation units.
Read more
Expanding the board of directors
As of January 2024, the Oncode Accelerator Foundation welcomes two new board members: Arnoud Huisman and Mark Krul. ‘They bring great experience and expertise to develop the program into the next phase’, says chairman of the Supervisory Board Fred Dom.
Read more
Cell therapy facility
Construction of the clean rooms for the Princess Máxima Centre's cell therapy facility has officially started. These dedicated rooms will facilitate the Cell and Gene Therapy workstream, where immune cells will be programmed to combat cancer. The facility is expected to be completed this year.
Read more
Next to the kick-off event we hosted last summer, we’ve been presenting our program at 4 events so far: Innovation for Health, ESMO, Figon DMD and the Nationaal Groeifonds event.
Read more
We’re kicking off 2024 with 39 partners involved in Oncode Accelerator: 19 private organizations, and 20 public organizations.
The launch of our program received notable media attention, capturing widespread interest. The exciting news was shared in ICT & Health, Het Financieele Dagblad, Medische Oncologie, Arts & Auto and MedNet.
The search for a cancer vaccine
Three local newspapers share an interview with Sjoerd van der Burg, lead of our Therapeutic Vaccines workstream, about the role of Oncode Accelerator in the search for a cancer vaccine. He emphasizes that our program was established to share expertise among all consortium partners and create a pipeline for cancer treatments.
Read more
Inspired by AI
Gerard van Westen, Platform lead Artificial Intelligence at Leiden University, was interviewed by C2W and EenVandaag about his passion for Artificial Intelligence and his aim to broaden and accelerate research into new therapies.
Read more
Big ambitions
Chief Operating Officer Friso Smit talked to Oncology Up-to-date about our program’s ambitions: “We hope that with more targeted therapies, patients will have a better quality of life and healthcare costs will be reduced.”
Read more
Share this article
Next Article